Tchaikapharma Highquality Medicines AD 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

9.47%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
55.64MRevenue
5.27MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

NIBC Holding N.V. provides corporate and retail banking products and services in the Netherlands, Germany, Belgium, the United Kingdom, and the Nordics. It operates through Corporate Client Offering, Retail Client Offering, and Treasury and Group Functions segments. The company offers merger and acquisition advisory services; equity sales and trading; debt and equity advisory services; leveraged and receivables finances; corporate lending; asset and cash flow finance; and project equity services. The company also offers mezzanine and equity solutions; and equities research, fixed income, and debt and equity capital market services. In addition, it provides mortgages; and savings products, as well as brokerage services under the NIBC Direct label. The company serves corporate clients, financial institutions, institutional investors, financial sponsors, family offices, entrepreneurial investors, and retail clients. NIBC Holding N.V. was founded in 1945 and is headquartered in The Hague, the Netherlands. As of December 21, 2020, NIBC Holding N.V. operates as a subsidiary of The Blackstone Group International Partners LLP.
Show More
CEO
Mr. Paulus A. M. de Wilt
Employees
726
Country
Other
ISIN
BG1100008074
WKN
000A14SWU

Listings

0 Comments

Share your thoughts

FAQs

What is Tchaikapharma Highquality Medicines AD stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange Tchaikapharma Highquality Medicines AD stocks are traded under the ticker 0R83.LSE.
What is Tchaikapharma Highquality Medicines AD revenue for the last year?▼
Tchaikapharma Highquality Medicines AD revenue for the last year amounts to 55.64M EUR.
What is Tchaikapharma Highquality Medicines AD net income for the last year?▼
0R83.LSE net income for the last year is 5.27M EUR.
How many employees does Tchaikapharma Highquality Medicines AD have?▼
As of November 2, 2026, the company has 726 employees.
In which sector is Tchaikapharma Highquality Medicines AD located?▼
Tchaikapharma Highquality Medicines AD operates in the Finance & Payments sector.
When did Tchaikapharma Highquality Medicines AD complete a stock split?▼
The last stock split for Tchaikapharma Highquality Medicines AD was on July 8, 2025 with a ratio of 1.0446623:1.
Where is Tchaikapharma Highquality Medicines AD headquartered?▼
Tchaikapharma Highquality Medicines AD is headquartered in The Hague, Other.